Crossmark

Pharmacogenetics of stimulant abuse liability: association of CDH13 variant with amphetamine response in a racially-heterogeneous sample of healthy young adults

Crossref DOI link: https://doi.org/10.1007/s00213-016-4462-z

Published Online: 2016-10-22

Published Print: 2017-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Leventhal, Adam M.

Kirkpatrick, Matthew G.

Pester, Mollie S.

McGeary, John E.

Swift, Robert M.

Sussman, Steve

Kahler, Christopher W.
Funding

Funding for this research was provided by:

National Institute on Drug Abuse (K08-DA025041)
License Information

Text and Data Mining valid from 2016-10-22

Version of Record valid from 2016-10-22
More Information

Article History

Received: 12 May 2016

Accepted: 12 October 2016

First Online: 22 October 2016

Compliance with ethical standards

: The study was reviewed and approved by the Institutional Review Board at the University of Southern California in accordance with the Code of Federal Regulations (Title 45, Part 46) adopted by the National Institutes of Health and the Office for Protection from Research Risks of the US Federal Government and was conducted ethically in accordance with the Helsinki Declaration of 1964 (revised 1989) and the National Advisory Council on Drug Abuse Recommended Guidelines for the Administration of Drugs to Human Subjects.

: The authors declare that they have no conflict of interest.

Document is current

Any future updates will be listed below